Published in Science on November 17, 2000
In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science (2008) 5.09
The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med (2001) 3.63
Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med (2001) 2.76
Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature (2004) 2.36
Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. Int J Parasitol (2007) 2.23
Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. Proc Natl Acad Sci U S A (2008) 1.96
Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva. PLoS Negl Trop Dis (2007) 1.63
Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease. PLoS Negl Trop Dis (2008) 1.62
Comparative salivary gland transcriptomics of sandfly vectors of visceral leishmaniasis. BMC Genomics (2006) 1.60
Vaccines to combat the neglected tropical diseases. Immunol Rev (2011) 1.55
Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania. PLoS Pathog (2009) 1.54
Severity of old world cutaneous leishmaniasis is influenced by previous exposure to sandfly bites in Saudi Arabia. PLoS Negl Trop Dis (2015) 1.48
Uninfected mosquito bites confer protection against infection with malaria parasites. Infect Immun (2007) 1.47
Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva. PLoS Med (2007) 1.47
An antivector vaccine protects against a lethal vector-borne pathogen. PLoS Pathog (2006) 1.44
Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production. Infect Immun (2004) 1.35
Flipping the paradigm on malaria transmission-blocking vaccines. Trends Parasitol (2008) 1.32
Structure and function of a "yellow" protein from saliva of the sand fly Lutzomyia longipalpis that confers protective immunity against Leishmania major infection. J Biol Chem (2011) 1.28
Leishmaniasis Vaccine: Where are We Today? J Glob Infect Dis (2010) 1.22
Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West Nile virus infection. PLoS One (2007) 1.21
High degree of conservancy among secreted salivary gland proteins from two geographically distant Phlebotomus duboscqi sandflies populations (Mali and Kenya). BMC Genomics (2006) 1.20
Synthetic glycovaccine protects against the bite of leishmania-infected sand flies. J Infect Dis (2006) 1.18
Sand flies, Leishmania, and transcriptome-borne solutions. Parasitol Int (2008) 1.16
The Anopheles gambiae salivary protein gSG6: an anopheline-specific protein with a blood-feeding role. Insect Biochem Mol Biol (2009) 1.15
Characterization of the antibody response to the saliva of Phlebotomus papatasi in people living in endemic areas of cutaneous leishmaniasis. Am J Trop Med Hyg (2011) 1.14
The immune response to sand fly salivary proteins and its influence on leishmania immunity. Front Immunol (2012) 1.10
Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia. PLoS Negl Trop Dis (2011) 1.08
Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted leishmania conferring ulcer-free protection. J Invest Dermatol (2012) 1.04
Lutzomyia longipalpis salivary gland homogenate impairs cytokine production and costimulatory molecule expression on human monocytes and dendritic cells. Infect Immun (2004) 1.03
The role of leishmania proteophosphoglycans in sand fly transmission and infection of the Mammalian host. Front Microbiol (2012) 1.03
Salivary gland transcriptomes and proteomes of Phlebotomus tobbi and Phlebotomus sergenti, vectors of leishmaniasis. PLoS Negl Trop Dis (2012) 1.02
Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis. PLoS Negl Trop Dis (2010) 1.02
Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival. PLoS Pathog (2009) 1.01
Hyaluronidase of bloodsucking insects and its enhancing effect on leishmania infection in mice. PLoS Negl Trop Dis (2008) 0.99
Association of human immune response to Aedes aegypti salivary proteins with dengue disease severity. Parasite Immunol (2012) 0.99
A new model of progressive visceral leishmaniasis in hamsters by natural transmission via bites of vector sand flies. J Infect Dis (2013) 0.97
Lundep, a sand fly salivary endonuclease increases Leishmania parasite survival in neutrophils and inhibits XIIa contact activation in human plasma. PLoS Pathog (2014) 0.97
First comparative transcriptomic analysis of wild adult male and female Lutzomyia longipalpis, vector of visceral leishmaniasis. PLoS One (2013) 0.96
Tsetse fly saliva accelerates the onset of Trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response. Infect Immun (2006) 0.95
Functional transcriptomics of wild-caught Lutzomyia intermedia salivary glands: identification of a protective salivary protein against Leishmania braziliensis infection. PLoS Negl Trop Dis (2013) 0.95
Cytokine responses of CD4+ T cells during a Plasmodium chabaudi chabaudi (ER) blood-stage infection in mice initiated by the natural route of infection. Malar J (2007) 0.95
DNA Vaccines against Protozoan Parasites: Advances and Challenges. J Biomed Biotechnol (2007) 0.95
Kinetics of antibody response in BALB/c and C57BL/6 mice bitten by Phlebotomus papatasi. PLoS Negl Trop Dis (2012) 0.92
Human cellular immune response to the saliva of Phlebotomus papatasi is mediated by IL-10-producing CD8+ T cells and Th1-polarized CD4+ lymphocytes. PLoS Negl Trop Dis (2011) 0.92
Sand-fly saliva-leishmania-man: the trigger trio. Front Immunol (2013) 0.92
KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi. PLoS Negl Trop Dis (2012) 0.91
Epidemiological study of the association between anti-Lutzomyia longipalpis saliva antibodies and development of delayed-type hypersensitivity to Leishmania antigen. Am J Trop Med Hyg (2010) 0.91
What's behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity. Infect Genet Evol (2014) 0.91
DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis. Acta Trop (2011) 0.89
Dual effect of Lutzomyia longipalpis saliva on Leishmania braziliensis infection is mediated by distinct saliva-induced cellular recruitment into BALB/c mice ear. BMC Microbiol (2013) 0.88
Delayed-type hypersensitivity to sand fly saliva in humans from a leishmaniasis-endemic area of Mali is Th1-mediated and persists to midlife. J Invest Dermatol (2012) 0.88
Analysis of salivary gland transcripts of the sand fly Lutzomyia ayacuchensis, a vector of Andean-type cutaneous leishmaniasis. Infect Genet Evol (2012) 0.88
The transmission of Leishmania infantum chagasi by the bite of the Lutzomyia longipalpis to two different vertebrates. Parasit Vectors (2012) 0.88
Comparative analysis of salivary gland transcriptomes of Phlebotomus orientalis sand flies from endemic and non-endemic foci of visceral leishmaniasis. PLoS Negl Trop Dis (2014) 0.88
Mechanisms of cellular invasion by intracellular parasites. Cell Mol Life Sci (2013) 0.86
Differential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectors. Parasit Vectors (2014) 0.85
Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses. PLoS One (2012) 0.85
Exosome Secretion by the Parasitic Protozoan Leishmania within the Sand Fly Midgut. Cell Rep (2015) 0.85
Vector saliva in vaccines for visceral leishmaniasis: a brief encounter of high consequence? Front Public Health (2014) 0.84
Repeated exposure to Lutzomyia intermedia sand fly saliva induces local expression of interferon-inducible genes both at the site of injection in mice and in human blood. PLoS Negl Trop Dis (2014) 0.83
Identifying vaccine targets for anti-leishmanial vaccine development. Expert Rev Vaccines (2014) 0.82
Expression plasticity of Phlebotomus papatasi salivary gland genes in distinct ecotopes through the sand fly season. BMC Ecol (2011) 0.82
Lack of protection of pre-immunization with saliva of long-term colonized Phlebotomus papatasi against experimental challenge with Leishmania major and saliva of wild-caught P. papatasi. Am J Trop Med Hyg (2010) 0.82
Characterization of the early inflammatory infiltrate at the feeding site of infected sand flies in mice protected from vector-transmitted Leishmania major by exposure to uninfected bites. PLoS Negl Trop Dis (2014) 0.82
New Insights Into the Transmissibility of Leishmania infantum From Dogs to Sand Flies: Experimental Vector-Transmission Reveals Persistent Parasite Depots at Bite Sites. J Infect Dis (2016) 0.81
Prostaglandin E2/leukotriene B4 balance induced by Lutzomyia longipalpis saliva favors Leishmania infantum infection. Parasit Vectors (2014) 0.81
LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis. Parasit Vectors (2014) 0.80
Meta-analysis of the effects of insect vector saliva on host immune responses and infection of vector-transmitted pathogens: a focus on leishmaniasis. PLoS Negl Trop Dis (2014) 0.80
Mosquito Saliva Increases Endothelial Permeability in the Skin, Immune Cell Migration, and Dengue Pathogenesis during Antibody-Dependent Enhancement. PLoS Pathog (2016) 0.80
Colonization of Phlebotomus papatasi changes the effect of pre-immunization with saliva from lack of protection towards protection against experimental challenge with Leishmania major and saliva. Parasit Vectors (2011) 0.79
Experimental models in vaccine research: malaria and leishmaniasis. Braz J Med Biol Res (2013) 0.79
The innate and adaptive response to mosquito saliva and Plasmodium sporozoites in the skin. Ann N Y Acad Sci (2015) 0.78
Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice. Int J Exp Pathol (2014) 0.78
An experimental test of the effects of behavioral and immunological defenses against vectors: do they interact to protect birds from blood parasites? Parasit Vectors (2014) 0.78
Phlebotomus papatasi SP15: mRNA expression variability and amino acid sequence polymorphisms of field populations. Parasit Vectors (2015) 0.77
Molecular Diagnosis and Identification of Leishmania Species in Jordan from Saved Dry Samples. Biomed Res Int (2016) 0.77
Kinetics of Anti-Phlebotomus perniciosus Saliva Antibodies in Experimentally Bitten Mice and Rabbits. PLoS One (2015) 0.77
Immunization with Culex tarsalis mosquito salivary gland extract modulates West Nile virus infection and disease in mice. Viral Immunol (2013) 0.77
Interleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies. J Infect Dis (2015) 0.77
New Insights on the Inflammatory Role of Lutzomyia longipalpis Saliva in Leishmaniasis. J Parasitol Res (2012) 0.77
A Listeria monocytogenes-based vaccine that secretes sand fly salivary protein LJM11 confers long-term protection against vector-transmitted Leishmania major. Infect Immun (2014) 0.77
Evaluation of the murine immune response to Xenopsylla cheopis flea saliva and its effect on transmission of Yersinia pestis. PLoS Negl Trop Dis (2014) 0.77
The Gut Microbiome of the Vector Lutzomyia longipalpis Is Essential for Survival of Leishmania infantum. MBio (2017) 0.76
Seasonal and Physiological Variations of Phlebotomus papatasi Salivary Gland Antigens in Central Iran. J Arthropod Borne Dis (2015) 0.76
Leishmaniasis vaccination: targeting the source of infection. J Exp Med (2001) 0.76
Concomitant Immunity Induced by Persistent Leishmania major Does Not Preclude Secondary Re-Infection: Implications for Genetic Exchange, Diversity and Vaccination. PLoS Negl Trop Dis (2016) 0.76
Cutaneous Leishmaniasis Vaccination: A Matter of Quality. Front Immunol (2016) 0.75
Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A Hypothesis. Front Immunol (2016) 0.75
Anopheline salivary protein genes and gene families: an evolutionary overview after the whole genome sequence of sixteen Anopheles species. BMC Genomics (2017) 0.75
Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge. PLoS One (2016) 0.75
Immunity to Lutzomyia whitmani Saliva Protects against Experimental Leishmania braziliensis Infection. PLoS Negl Trop Dis (2016) 0.75
Functional variations in MBL2 gene are associated with cutaneous leishmaniasis in the Amazonas state of Brazil. Genes Immun (2015) 0.75
The development of a murine model for Forcipomyia taiwana (biting midge) allergy. PLoS One (2014) 0.75
Human immune response to salivary proteins of wild-caught Phlebotomus papatasi. Parasitol Res (2016) 0.75
Insights into the sand fly saliva: Blood-feeding and immune interactions between sand flies, hosts, and Leishmania. PLoS Negl Trop Dis (2017) 0.75
Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature (2011) 5.41
Cervical screening in an inner city area: response to a call system in general practice. BMJ (1988) 4.19
Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med (1998) 3.68
A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol (2000) 3.47
Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis (1999) 2.92
Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem (1997) 2.76
Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med (2001) 2.76
Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med (1998) 2.30
Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science (2014) 2.20
An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major. J Immunol (2000) 2.11
The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge. J Immunol (2001) 1.72
The role of phosphoglycans in Leishmania-sand fly interactions. Proc Natl Acad Sci U S A (2000) 1.68
Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol (2012) 1.62
Molecular characterisation of ninein, a new coiled-coil protein of the centrosome. J Cell Sci (1996) 1.59
A muscle-type tropomyosin in human fibroblasts: evidence for expression by an alternative RNA splicing mechanism. Proc Natl Acad Sci U S A (1985) 1.59
Delayed-type hypersensitivity to Phlebotomus papatasi sand fly bite: An adaptive response induced by the fly? Proc Natl Acad Sci U S A (2000) 1.58
Evidence that the vectorial competence of phlebotomine sand flies for different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycan. Proc Natl Acad Sci U S A (1994) 1.52
Protein S deficiency in HIV associated ischaemic stroke: an epiphenomenon of HIV infection. J Neurol Neurosurg Psychiatry (2005) 1.48
Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur J Immunol (1995) 1.45
The salivary apyrase of the blood-sucking sand fly Phlebotomus papatasi belongs to the novel Cimex family of apyrases. J Exp Biol (2001) 1.40
Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis. Eur J Immunol (2000) 1.36
The vectorial competence of Phlebotomus sergenti is specific for Leishmania tropica and is controlled by species-specific, lipophosphoglycan-mediated midgut attachment. Parasitology (2000) 1.27
Changes in lipophosphoglycan and gene expression associated with the development of Leishmania major in Phlebotomus papatasi. Parasitology (1995) 1.22
Reporting standards for percutaneous interventions in dialysis access. Technology Assessment Committee. J Vasc Interv Radiol (2000) 1.21
Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63). Mol Microbiol (1998) 1.20
Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major. Infect Immun (2000) 1.19
The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. J Immunol (1996) 1.09
Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes (1995) 1.09
Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis. J Immunol (1983) 1.08
Quality improvement guidelines for percutaneous nephrostomy. J Vasc Interv Radiol (2001) 1.08
The role of the lipophosphoglycan of Leishmania in vector competence. Parasitology (1994) 1.03
Intra-species and stage-specific polymorphisms in lipophosphoglycan structure control Leishmania donovani-sand fly interactions. Biochemistry (1999) 1.02
Quality improvement guidelines for percutaneous permanent inferior vena cava filter placement for the prevention of pulmonary embolism. SCVIR Standards of Practice Committee. J Vasc Interv Radiol (2001) 1.02
Care of the adolescent sexual assault victim. Pediatrics (2001) 1.02
Pregnancy among teenagers. Can Med Assoc J (1981) 1.01
Myelopathy associated with human T cell lymphotropic virus type I (HTLV-I) in natal, South Africa. A clinical and investigative study in 24 patients. Brain (1990) 1.00
Guidelines regarding HIV and other bloodborne pathogens in vascular/interventional radiology. SCVIR Technology Assessment Committee. J Vasc Interv Radiol (1997) 1.00
Plasticity of T reg at infected sites. Mucosal Immunol (2010) 0.98
Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers. Trans R Soc Trop Med Hyg (2004) 0.98
Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients. J Neurol Neurosurg Psychiatry (1991) 0.98
Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease. Exp Parasitol (1998) 0.97
Screening recommendations for gestational diabetes mellitus. Am J Obstet Gynecol (1991) 0.97
Serum cardiac troponin T levels during treatment of early-stage breast cancer. J Clin Oncol (1995) 0.96
Blood pressure-measuring devices in rural South Africa: an audit conducted by the SASPI team in the Agincourt field site. Cardiovasc J S Afr (2006) 0.94
Quality improvement guidelines for percutaneous management of the thrombosed or dysfunctional dialysis access. Standards of Practice Committee of the Society of Cardiovascular & Interventional Radiology. J Vasc Interv Radiol (1999) 0.93
Regulatory role of suppressive motifs from commensal DNA. Mucosal Immunol (2012) 0.93
Management of HIV-associated focal brain lesions in developing countries. QJM (2004) 0.92
Reporting standards for central venous access. Technology Assessment Committee. J Vasc Interv Radiol (2000) 0.92
Condom use by adolescents. Pediatrics (2001) 0.90
Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3+ CD4 cells in blood or spleen. Parasite Immunol (2010) 0.89
Quality improvement guidelines for central venous access. The Standards of Practice Committee of the Society of Cardiovascular & Interventional Radiology. J Vasc Interv Radiol (1997) 0.89
Cold agglutinins and cryoglobulins in a patient with acute aortoarteritis (Takayasu's disease) and tuberculous lymphadenitis. Rheumatology (Oxford) (2000) 0.89
Diagnostic criteria for carotid duplex sonography. AJR Am J Roentgenol (1988) 0.88
Quality improvement guidelines for percutaneous transhepatic cholangiography and biliary drainage. Society of Cardiovascular and Interventional Radiology. J Vasc Interv Radiol (1997) 0.87
Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. SCVIR Standards of Practice Committee. J Vasc Interv Radiol (2001) 0.87
Effects of lithium chloride on induction and expression of methylphenidate sensitization. Eur J Pharmacol (2001) 0.86
Quality improvement guidelines for percutaneous transcatheter embolization. SCVIR Standards of Practice Committee. Society of Cardiovascular & Interventional Radiology. J Vasc Interv Radiol (1997) 0.86
Activation of factor X and prothrombin in antithrombin-III depleted plasma: the effects of heparin. Thromb Res (1982) 0.85
Reduced risk of toxoplasma encephalitis in HIV-infected patients--a prospective study from Gauteng, South Africa. Int J STD AIDS (2007) 0.85
Reporting standards for endovascular repair of saccular intracranial cerebral aneurysms. AJNR Am J Neuroradiol (2010) 0.84
Intraventricular neurocysticercosis causing acute unilateral hydrocephalus. Afr J Psychiatry (Johannesbg) (2010) 0.84
Reporting standards for uterine artery embolization for the treatment of uterine leiomyomata. J Vasc Interv Radiol (2001) 0.83
Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma. Thromb Res (1982) 0.83
The salivary adenosine/AMP content of Phlebotomus argentipes Annandale and Brunetti, the main vector of human kala-azar. J Parasitol (2001) 0.83
Skin dendritic cells in murine cutaneous leishmaniasis. Immunobiology (2001) 0.82
Optic neuritis in an urban black African community. Eye (Lond) (2001) 0.82
Spinal cord schistosomiasis. A clinical, laboratory and radiological study, with a note on therapeutic aspects. Brain (1991) 0.81
The factor VIII-independent activation of factor X by factors IXa and VII in plasma. Thromb Res (1981) 0.81
Case reports: postpartum cerebral angiopathy in a patient with chronic migraine with aura. Headache (2000) 0.81
Frequency of Wolbachia infection in laboratory and field sand fly (Diptera: Psychodidae) populations. J Am Mosq Control Assoc (1999) 0.80
Effect of human circumsporozoite antibodies in Plasmodium-infected Anopheles (Diptera: Culicidae). J Med Entomol (1989) 0.80
Reporting standards for transjugular intrahepatic portosystemic shunts. Technology Assessment Committee of the SCVIR. J Vasc Interv Radiol (1997) 0.80
SCVIR reporting standards for the treatment of acute limb ischemia with use of transluminal removal of arterial thrombus. J Vasc Interv Radiol (2001) 0.80
Quality improvement guidelines for image-guided percutaneous biopsy in adults: Society of Cardiovascular & Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol (1997) 0.79
Parasite-host relationships: in-situ study of Leishmania spp. in resistant and susceptible mice. Ann Trop Med Parasitol (1995) 0.78
Leishmaniasis in the United States military. Mil Med (1998) 0.78
Total dose iron infusion: safety and efficacy in predialysis patients. Ren Fail (2000) 0.78
Acute limb ischemia. Emerg Med Clin North Am (1992) 0.77
Relationship between the neuroprotective effects of insulin-like growth factor-1 and 17β-oestradiol in human neuroblasts. J Neuroendocrinol (2012) 0.76
Carotid sonography contralateral to severe stenosis. AJR Am J Roentgenol (1991) 0.75
Genetic variability among populations of the sand fly Lutzomyia (Lutzomyia) longipalpis (Diptera: Psychodidae) from Central America. J Med Entomol (1998) 0.75
Conventional vs color carotid Doppler imaging. AJR Am J Roentgenol (1991) 0.75
Percutaneous transluminal angioplasty versus surgery for limb-threatening ischemia. J Vasc Surg (1990) 0.75
Hepatitis C virus related cryoglobulinemic glomerulonephritis. J Assoc Physicians India (2002) 0.75
Leishmania major and Toxoplasma gondii have opposite effects on cytokine synthesis by macrophages. Mem Inst Oswaldo Cruz (1996) 0.75
Sexual abuse of children and sexually transmitted diseases: implications for physicians. CMAJ (1989) 0.75
Albright's hereditary osteodystrophy with hypoparathyroidism. J Assoc Physicians India (1996) 0.75
Massive hemolysis: a rare complication of transcatheter coil embolization. J Vasc Interv Radiol (1996) 0.75
Mononuclear phagocytes and dendritic leukocytes in the skin. Clin Dermatol (1997) 0.75
New-onset seizures in HIV-infected patients. A review and guide to management. S Afr Med J (2001) 0.75
Reasons for patient referral to occupational therapy units by health care professionals. J Allied Health (1985) 0.75
Worsening right flank pain over a 24-hr period. Acad Radiol (1994) 0.75
Major histocompatibility complex class I presentation of exogenously acquired minor alloantigens initiates skin allograft rejection. Eur J Immunol (1997) 0.75
A false-positive hepatobiliary scan in a patient with cystic fibrosis. Clin Nucl Med (1988) 0.75